Full Professor
Strategic program(s):
Biography
Marjolein de Bruin-Weller is a dermatologist and full professor in atopic dermatitis and head of the National Expertise Center of Atopic Dermatitis, situated in the dpt. of Dermatology and Allergology of the University Medical Center of Utrecht, The Netherlands
After her training in physiotherapy (1979-1983), she started her medical training at the University of Leiden and graduated in 1990. After this she started as a PhD candidate at Astmacenter Heideheuvel, Hilversum, the Netherlands, supervised by Professor Jan de Monchy (allergologist University Medical Center Groningen, Professor Henk Jansen (pulmonologist University Medical Center Amsterdam) and dr. Frank Weller (pulmonologist University Medical Center Amsterdam). In 1997 she defended her PhD thesis “Dynamics of the allergic reaction in the airways and the skin” at the University of Groningen.
She started her training in dermatology in 1997 at the department of Dermatology/Allergology of the University Medical Center Utrecht and became a staff member at this department in 2001, with a special focus on atopic dermatitis. In October 2018 she was appointed as Associate Professor and in December 2021 as full professor in atopic dermatitis.
Her major interest is clinical and translational research in atopic dermatitis. She is principle investigator in several clinical trials and investigator-initiated studies focused on difficult to treat atopic dermatitis and systemic immunosuppressive and immuno-modulating treatment. For translational, she closely collaborates with the Center of Translational Immunology in Utrecht (Professor Femke van Wijk).
Together with Femke van Wijk, Marjolein de Bruin leads the Utrecht Atopic Dermatitis Research Group.
In 2018 she imitated the BioDay Registry in the Netherlands together with dr. Marie-Louise Schuttelaar from the department of Dermatology of the University Medical Center of Groningen. This register is focused on new systemic treatments in atopic dermatitis and includes a lot of data concerning atopic dermatitis (signs, symptoms, quality of life, work impairment) as well as data concerning atopic co-morbidities. At the end of 2021, 14 centers in the Netherlands are participating in the BioDay Registry and >1000 patients are included.
Marjolein de Bruin-Weller is a member of the Expertise group Allergy and Eczema Dutch Society of Dermatology and Venereology), the European Task Force of Atopic Dermatitis (ETFAD) , the International Eczema Council (IEC) and the GA²LEN ADCARE Task Force. She is chair of the advisory board Dutch Patient Society for Atopic Dermatitis (VMCE).
Research aim
By combining clinical and translational research the goal of our research is to improve personalized treatment of adult and pediatric atopic dermatitis patients . The ultimate goal is to achieve disease modification and prevent atopic comorbidities.Research aim
Our mission is to comprehensively understand, monitor, and target immune-mediated inflammatory diseases such as IBD, AD and systemic autoimmune diseases. We aim to unravel (tissue) immune dysregulation and induce long-lasting disease modification.Chair working group “dure geneesmiddelen” NVDV
Advisory board member Aslan
Advisory board member Arena
Advisory board member and speaker Almirall
Advisory board member Eli Lilly
Advisory board member and speakerJanssen
Consultant, advisory board member and speaker Leo Pharma
Consultant, advisory board member and speaker Pfizer
Member Steering committee of the ADCARE Task Force
Member “ geneesmiddelencommissie FMS”
ExComm Member GA²LEN
consultant,advisory board member and speaker AbbVie
Advisory board member and speaker Galderma
Member Horizonscan inflammatory diseases (Zorginstituut Nederland)
Consultant, advisory board member and speaker Regeneron
Consultant, advisory board member and speaker Sanofi-Genzyme
Member International Eczema Council (IEC)
Member European Task Force of Atopic Dermatitis (ETFAD)
Chair Advisory board Dutch patient society for atopic dermatitis (VMCE)
